Growing community of inventors

Tokyo, Japan

Yasuki Kamai

Average Co-Inventor Count = 4.55

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Yasuki KamaiAtsushi Urano (3 patents)Yasuki KamaiJun Hasegawa (2 patents)Yasuki KamaiTakako Kimura (2 patents)Yasuki KamaiToshinori Agatsuma (2 patents)Yasuki KamaiToshiaki Ohtsuka (2 patents)Yasuki KamaiTatsuji Matsuoka (2 patents)Yasuki KamaiYumi Matsui (2 patents)Yasuki KamaiChigusa Yoshimura (2 patents)Yasuki KamaiReimi Kawaida (2 patents)Yasuki KamaiChiaki Ishii (2 patents)Yasuki KamaiTeiji Wada (2 patents)Yasuki KamaiSaori Ishida (2 patents)Yasuki KamaiTomomi Iwata (2 patents)Yasuki KamaiJun Hasegawa (1 patent)Yasuki KamaiAtsushi Urano (1 patent)Yasuki KamaiTakako Kimura (1 patent)Yasuki KamaiYasuki Kamai (5 patents)Atsushi UranoAtsushi Urano (6 patents)Jun HasegawaJun Hasegawa (110 patents)Takako KimuraTakako Kimura (19 patents)Toshinori AgatsumaToshinori Agatsuma (12 patents)Toshiaki OhtsukaToshiaki Ohtsuka (11 patents)Tatsuji MatsuokaTatsuji Matsuoka (9 patents)Yumi MatsuiYumi Matsui (8 patents)Chigusa YoshimuraChigusa Yoshimura (5 patents)Reimi KawaidaReimi Kawaida (4 patents)Chiaki IshiiChiaki Ishii (3 patents)Teiji WadaTeiji Wada (3 patents)Saori IshidaSaori Ishida (2 patents)Tomomi IwataTomomi Iwata (2 patents)Jun HasegawaJun Hasegawa (3 patents)Atsushi UranoAtsushi Urano (2 patents)Takako KimuraTakako Kimura (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Daiichi Sankyo Company, Limited (5 from 440 patents)


5 patents:

1. 12319736 - Combination of antibody-drug conjugate and immune checkpoint inhibitor

2. 11273155 - Combination of antibody-drug conjugate and immune checkpoint inhibitor

3. 9931401 - Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitor

4. 9714298 - Anti-FGFR2 antibodies and methods of use thereof for treating cancer

5. 9481733 - Anti-FGFR2 antibodies and pharmaceutical compositions thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…